Literature DB >> 21730951

Microwave-assisted one-pot synthesis of N-succinimidyl-4[ ¹⁸F]fluorobenzoate ([¹⁸F]SFB).

Shuang Hou1, Duy Linh Phung, Wei-Yu Lin, Ming-wei Wang, Kan Liu, Clifton Kwang-Fu Shen.   

Abstract

Biomolecules, including peptides¹⁻⁹, proteins¹⁰⁻¹¹, and antibodies and their engineered fragments¹²⁻¹⁴, are gaining importance as both potential therapeutics and molecular imaging agents. Notably, when labeled with positron-emitting radioisotopes (e.g., Cu-64, Ga-68, or F-18), they can be used as probes for targeted imaging of many physiological and pathological processes.¹⁵⁻¹⁸ Therefore, significant effort has devoted to the synthesis and exploration of ¹⁸F-labeled biomolecules. Although there are elegant examples of the direct ¹⁸F-labeling of peptides,¹⁹⁻²² the harsh reaction conditions (i.e., organic solvent, extreme pH, high temperature) associated with direct radiofluorination are usually incompatible with fragile protein samples. To date, therefore, the incorporation of radiolabeled prosthetic groups into biomolecules remains the method of choice.²³(,)²⁴ N-Succinimidyl-4-[¹⁸F]fluorobenzoate ([¹⁸F]SFB),²⁵⁻³⁷ a Bolton-Hunter type reagent that reacts with the primary amino groups of biomolecules, is a very versatile prosthetic group for the ¹⁸F-labeling of a wide spectrum of biological entities, in terms of its evident in vivo stability and high radiolabeling yield. After labeling with [¹⁸F]SFB, the resulting [F]fluorobenzoylated biomolecules could be explored as potential PET tracers for in vivo imaging studies.¹ Most [¹⁸F]SFB radiosyntheses described in the current literatures require two or even three reactors and multiple purifications by using either solid phase extraction (SPE) or high-performance liquid chromatography (HPLC). Such lengthy processes hamper its routine production and widespread applications in the radiolabeling of biomolecules. Although several module-assisted [¹⁸F]SFB syntheses have been reported²⁹⁻³²,⁴¹⁻⁴² they are mainly based on complicated and lengthy procedures using costly commercially-available radiochemistry boxes (Table 1). Therefore, further simplification of the radiosynthesis of [¹⁸F]SFB using a low-cost setup would be very beneficial for its adaption to an automated process. Herein, we report a concise preparation of [¹⁸F]SFB, based on a simplified one-pot microwave-assisted synthesis (Figure 1). Our approach does not require purification between steps or any aqueous reagents. In addition, microwave irradiation, which has been used in the syntheses of several PET tracers,³⁸⁻⁴¹ can gives higher RCYs and better selectivity than the corresponding thermal reactions or they provide similar yields in shorter reaction times.³⁸Most importantly, when labeling biomolecules, the time saved could be diverted to subsequent bioconjugation or PET imaging step. ²⁸(,)⁴³The novelty of our improved [¹⁸F]SFB synthesis is two-fold: (1) the anhydrous deprotection strategy requires no purification of intermediate(s) between each step and (2) the microwave-assisted radiochemical transformations enable the rapid, reliable production of [¹⁸F]SFB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730951      PMCID: PMC3197048          DOI: 10.3791/2755

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  32 in total

Review 1.  Recent progress in fluorine-18 labelled peptide radiopharmaceuticals.

Authors:  S M Okarvi
Journal:  Eur J Nucl Med       Date:  2001-07

2.  Improved synthesis of N-succinimidyl 4-[18F]fluorobenzoate and its application to the labeling of a monoclonal antibody fragment.

Authors:  G Vaidyanathan; M R Zalutsky
Journal:  Bioconjug Chem       Date:  1994 Jul-Aug       Impact factor: 4.774

3.  Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.

Authors:  Ralf Bergmann; Matthias Scheunemann; Christoph Heichert; Peter Mäding; Holm Wittrisch; Marion Kretzschmar; Heike Rodig; Dirk Tourwé; Koen Iterbeke; Kris Chavatte; Daniel Zips; Jean Claude Reubi; Bernd Johannsen
Journal:  Nucl Med Biol       Date:  2002-01       Impact factor: 2.408

4.  Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET.

Authors:  S Zijlstra; J Gunawan; W Burchert
Journal:  Appl Radiat Isot       Date:  2003-02       Impact factor: 1.513

5.  Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death.

Authors:  J Toretsky; A Levenson; I N Weinberg; J F Tait; A Uren; R C Mease
Journal:  Nucl Med Biol       Date:  2004-08       Impact factor: 2.408

6.  18F-labelled annexin V: a PET tracer for apoptosis imaging.

Authors:  Yoshihiro Murakami; Hiroyuki Takamatsu; Junichi Taki; Mitsuyoshi Tatsumi; Akihiro Noda; Rikiya Ichise; Jonathan F Tait; Shintaro Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-10       Impact factor: 9.236

7.  MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide.

Authors:  Xiaoyuan Chen; Ryan Park; Yingping Hou; Vazgen Khankaldyyan; Ignacio Gonzales-Gomez; Michel Tohme; James R Bading; Walter E Laug; Peter S Conti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-29       Impact factor: 9.236

8.  Radiolabelling of isopeptide N epsilon-(gamma-glutamyl)-L-lysine by conjugation with N-succinimidyl-4-[18F]fluorobenzoate.

Authors:  F Wüst; C Hultsch; R Bergmann; B Johannsen; T Henle
Journal:  Appl Radiat Isot       Date:  2003-07       Impact factor: 1.513

9.  A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation.

Authors:  H J Wester; K Hamacher; G Stöcklin
Journal:  Nucl Med Biol       Date:  1996-04       Impact factor: 2.408

10.  Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity.

Authors:  P K Garg; S Garg; M R Zalutsky
Journal:  Bioconjug Chem       Date:  1991 Jan-Feb       Impact factor: 4.774

View more
  5 in total

1.  Highly efficient click labeling using 2-[¹⁸F]fluoroethyl azide and synthesis of an ¹⁸FN-hydroxysuccinimide ester as conjugation agent.

Authors:  Dong Zhou; Wenhua Chu; Carmen S Dence; Robert H Mach; Michael J Welch
Journal:  Nucl Med Biol       Date:  2012-07-04       Impact factor: 2.408

2.  ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging.

Authors:  Tove Olafsen; Shannon J Sirk; Sebastian Olma; Clifton K-F Shen; Anna M Wu
Journal:  Tumour Biol       Date:  2012-03-06

3.  Synthesis and evaluation of (68)Ga-labeled DOTA-2-deoxy-D-glucosamine as a potential radiotracer in μPET imaging.

Authors:  Zhi Yang; Chiyi Xiong; Rui Zhang; Hua Zhu; Chun Li
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

4.  Fully automated production of diverse 18F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification.

Authors:  Mark Lazari; Jeffrey Collins; Bin Shen; Mohammed Farhoud; Daniel Yeh; Brandon Maraglia; Frederick T Chin; David A Nathanson; Melissa Moore; R Michael van Dam
Journal:  J Nucl Med Technol       Date:  2014-07-17

Review 5.  Current outlook on radionuclide delivery systems: from design consideration to translation into clinics.

Authors:  Oleksii O Peltek; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2019-08-21       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.